|
1
|
Jemal A, Thomas A, Murray T and Thun M:
Cancer statistics, 2002. CA Cancer J Clin. 52:23–47. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Belinsky SA: Gene-promoter
hypermethylation as a biomarker in lung cancer. Nat Rev Cancer.
4:707–717. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weir BA, Woo MS, Getz G, Perner S, Ding L,
Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, et al:
Characterizing the cancer genome in lung adenocarcinoma. Nature.
450:893–898. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ding L, Getz G, Wheeler DA, Mardis ER,
McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan
MB, et al: Somatic mutations affect key pathways in lung
adenocarcinoma. Nature. 455:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang W, Yao YW, Zeng JL, Liang WJ, Wang L,
Bai CQ, Liu CH and Song Y: Prognostic value of FGFR1 gene
copy number in patients with non-small cell lung cancer: A
meta-analysis. J Thorac Dis. 6:803–809. 2014.PubMed/NCBI
|
|
6
|
Weiss J, Sos ML, Seidel D, Peifer M,
Zander T, Heuckmann JM, Ullrich RT, Menon R, Maier S, Soltermann A,
et al: Frequent and focal FGFR1 amplification associates
with therapeutically tractable FGFR1 dependency in squamous cell
lung cancer. Sci Transl Med. 2:62ra932010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mok TS, Wu YL, Thongprasert S, Yang CH,
Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, et
al: Gefitinib or carboplatin-paclitaxel in pulmonary
adenocarcinoma. N Engl J Med. 361:947–957. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pao W and Chmielecki J: Rational,
biologically based treatment of EGFR-mutant non-small-cell lung
cancer. Nat Rev Cancer. 10:760–774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pykäläinen A, Boczkowska M, Zhao H,
Saarikangas J, Rebowski G, Jansen M, Hakanen J, Koskela EV, Peränen
J, Vihinen H, et al: Pinkbar is an epithelial-specific BAR domain
protein that generates planar membrane structures. Nat Struct Mol
Biol. 18:902–907. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saarikangas J, Zhao H, Pykäläinen A,
Laurinmäki P, Mattila PK, Kinnunen PK, Butcher SJ and Lappalainen
P: Molecular mechanisms of membrane deformation by I-BAR domain
proteins. Curr Biol. 19:95–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mattila PK, Pykäläinen A, Saarikangas J,
Paavilainen VO, Vihinen H, Jokitalo E and Lappalainen P:
Missing-in-metastasis and IRSp53 deform PI(4,5)P2-rich
membranes by an inverse BAR domain-like mechanism. J Cell Biol.
176:953–964. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao H, Pykäläinen A and Lappalainen P:
I-BAR domain proteins: Linking actin and plasma membrane dynamics.
Curr Opin Cell Biol. 23:14–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Z, Shi Z and Baumgart T: Regulation
of membrane-shape transitions induced by I-BAR domains. Biophys J.
109:298–307. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scita G, Confalonieri S, Lappalainen P and
Suetsugu S: IRSp53: Crossing the road of membrane and actin
dynamics in the formation of membrane protrusions. Trends Cell
Biol. 18:52–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vingadassalom D, Kazlauskas A, Skehan B,
Cheng HC, Magoun L, Robbins D, Rosen MK, Saksela K and Leong JM:
Insulin receptor tyrosine kinase substrate links the E. coli
O157:H7 actin assembly effectors Tir and EspFU during
pedestal formation. Proc Natl Acad Sci USA. 106:6754–6759. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sudhaharan T, Sem KP, Liew HF, Yu YH, Goh
WI, Chou AM and Ahmed S: The Rho GTPase Rif signals through IRTKS,
Eps8 and WAVE2 to generate dorsal membrane ruffles and filopodia. J
Cell Sci. 129:2829–2840. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Funato Y, Terabayashi T, Suenaga N, Seiki
M, Takenawa T and Miki H: IRSp53/Eps8 complex is important for
positive regulation of Rac and cancer cell motility/invasiveness.
Cancer Res. 64:5237–5244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu D, Zhan XH, Zhao XF, Williams MS, Carey
GB, Smith E, Scott D, Zhu J, Guo Y, Cherukuri S, et al: Mice
deficient in MIM expression are predisposed to lymphomagenesis.
Oncogene. 31:3561–3568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chao A, Tsai CL, Jung SM, Chuang WC, Kao
C, Hsu A, Chen SH, Lin CY, Lee YC, Lee YS, et al: BAI1-associated
protein 2-like 1 (BAIAP2L1) is a potential biomarker in ovarian
cancer. PLoS One. 10:e01330812015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Williams SV, Hurst CD and Knowles MA:
Oncogenic FGFR3 gene fusions in bladder cancer. Hum Mol Genet.
22:795–803. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giaccone G: Epidermal growth factor
receptor inhibitors in the treatment of non-small-cell lung cancer.
J Clin Oncol. 23:3235–3242. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Herbst RS, Onn A and Sandler A:
Angiogenesis and lung cancer: Prognostic and therapeutic
implications. J Clin Oncol. 23:3243–3256. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karamouzis MV and Papavassiliou AG: The
IGF-1 network in lung carcinoma therapeutics. Trends Mol Med.
12:595–602. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang YP, Huang LY, Sun WM, Zhang ZZ, Fang
JZ, Wei BF, Wu BH and Han ZG: Insulin receptor tyrosine kinase
substrate activates EGFR/ERK signalling pathway and promotes cell
proliferation of hepatocellular carcinoma. Cancer Lett. 337:96–106.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Naugler WE, Sakurai T, Kim S, Maeda S, Kim
K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due
to sex differences in MyD88-dependent IL-6 production. Science.
317:121–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsu LH, Chu NM and Kao SH: Estrogen,
estrogen receptor and lung cancer. Int J Mol Sci. 18:E17132017.
View Article : Google Scholar : PubMed/NCBI
|
